Show
Sort by
-
- Journal Article
- A1
- open access
Molecular imaging of tumor-associated angiogenesis using a novel magnetic resonance imaging contrast agent targeting αvβ3 integrin
-
Cisplatin-modified de Gramont in second-line therapy for pancreatic adenocarcinoma
-
Standardized added metabolic activity (SAM) IN 18F-FDG PET assessment of treatment response in colorectal liver metastases
-
Pharmacologic activation of tumor hypoxia: a means to increase tumor 2-deoxy-2-[18F]fluoro-D-glucose uptake?
-
Single-photon emission computed tomographic imaging of the early time course of therapy-induced cell death using technetium 99m tricarbonyl His-annexin A5 in a colorectal cancer xenograft model
-
- Journal Article
- A1
- open access
Clinical procedure for colon carcinoma tissue sampling directly affects the cancer marker-capacity of VEGF family members
-
Cisplatin-modified de Gramont in second line therapy for pancreatic adenocarcinoma
-
Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases
-
99mTc-labeled tricarbonyl His-CNA35 as an imaging agent for the detection of tumor vasculature
-
An evaluation of FDG-PET as a predictor of metabolic response to chemotherapy in metastatic colorectal cancer patients (mCRC)